This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert W. Hamill, MD
Department of Neurology Medical Center Hospital of Vermont Burlington, VT 05401

Curtis G. Benesch, MD; Christopher Cox, PhD
Rochester, NY

Keith D. McDaniel, MD
Sacramento, Calif

Arch Neurol. 1995;52(2):128.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In reply

We thank Panisset and colleagues for their supportive comments regarding our initial characterization of subjects with clinical dementia rating scores of 3, 4, and 5, using the Glasgow Coma Scale (GCS.)¹ We fully agree that it is important to assess patients with end-stage dementia and to develop means by which to stratify their function. Our initial goals were to apply a well-characterized, internationally used and standardized, easily performed bedside test (time of performance less than 5 minutes) that could be administered by nurses and physicians without expertise in neuropsychology or neurology, and determine if patients with severe dementia could be stratified. Our results indicate that patients in the groups with clinical dementia rating scores of 4 and 5 may be stratified with this simple approach.

We agree with Panisset et al² that in comparison with the GCS, the Severe Impairment Battery (SIB) provides a more detailed . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?